$CSTM

Becker Marcus sold $363K of CSTM

Becker Marcus (SVP CPO) sold 10,391 shares of CONSTELLIUM SE (CSTM) at $34.93 ($0.36M total) on 2026-05-28.

Original reporting
SEC EDGAR · Becker Marcus
Published Jun 1, 2026, 5:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 5:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CSTM
Neutral
medium confidence
Mentioned
$CSTM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSTMNeutralLow
01

Why it matters

The disclosure may slightly affect short-term sentiment, but it does not introduce new company fundamentals or a tradable event like earnings, M&A, or regulatory action.

02

Market read

Traders may note the insider sale as a mild negative/neutral sentiment datapoint, but it is unlikely to drive a durable repricing alone.

03

What to watch

The filing doesn’t specify intent beyond the transaction code; without context on prior insider trades or total ownership trend, the signal is weak.

Relevance 6/10Novelty 6/10Timing: Filed June 1, 2026; sale occurred May 28, 2026.

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Constel­lium SE.

Company-level read

Ticker impact

$CSTMNeutralMedium confidence
Context

Constellium SE SVP CPO Becker Marcus sold 10,391 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited immediate impact; any effect would be small and short-lived unless followed by additional insider activity or company-specific news.

Evidence & confidence

The filing is a routine Form 4 open-market sale; no 10b5-1 plan is cited, but the article provides no earnings/contract/litigation/drug/trade catalyst.

Market effects

Minimal—this is company-specific insider activity with no stated sector-wide development.

Minimal—no geographic or cross-border operational change mentioned.

Minimal—no global deal/regulatory action tied to the issuer in the filing.

Counterpoint

A single insider sale can reflect diversification or liquidity needs rather than bearish expectations, especially when not linked to performance guidance changes.

Key entities

  • Constellium SE

    Subject of the insider transaction disclosure; SVP CPO sold shares via open-market sale.

  • Becker Marcus

    SVP CPO who executed the sale; holdings reduced to 16,784 shares after the transaction.

Related articles

$CSTMHighAI 9/10

Constellium Raises Full-Year Outlook After Second-Quarter Earnings Top Expectations

Constellium SE (NYSE:CSTM) reported stronger-than-expected second-quarter results on Wednesday and increased its financial guidance for the full year, sending its shares more than 3% higher in pre-market trading. The aluminum products manufacturer posted adjusted earnings of $1.04 per share, comfortably ahead of analysts' consensus estimate of $0.71. Quarterly revenue rose to $2.75 billion, exceeding expectations of $2.37 billion and increasing 31% from $2.1 billion in the same period last year.

$CSTMMedAI 8/10

Constellium SE Q2 2026 Earnings Call Summary

Constellium SE reported record Q2 2026 Adjusted EBITDA of $310 million (excluding metal price lag) and raised full-year 2026 guidance to EUR 980 million to EUR 1.02 billion. It expects free cash flow above EUR 300 million and said recycling benefits may taper in H2 2026. The company also discussed aerospace demand, scrap spreads, and a potential European scrap export tax.

$CSTMMed

CONSTELLIUM SE (CSTM): Results of Operations and Financial Condition

CONSTELLIUM SE (CSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. cstm-20260729 false 0001563411 0001563411 2026-07-29 2026-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

$CSTMMedAI 8/10

Constellium (NYSE:CSTM) Shares Pass Above 200 Day Moving Average – Here’s Why

Constellium SE (NYSE:CSTM) shares moved above their 200-day moving average on Monday, trading up to $33.54 and last at $33.26 versus a 200-day average near $23.72. The stock also saw analyst changes: Zacks upgraded to strong-buy; Deutsche Bank reiterated buy with a $40 target; JPMorgan raised its $34 target. The company reported April 29 EPS of $1.42 and revenue of $2.46B, and approved a $300M buyback.